Bulletin
Investor Alert

May 13, 2020, 1:55 p.m. EDT

Cancer Vaccines Market- Revenue Growth, Market Status / CAGR of around 17.5% over the forecast period, 2020-2028

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Bristol Myers Squibb Co. (BMY)
  • X
    Merck & Co. Inc. (MRK)
  • X
    VBI Vaccines Inc. (VBIV)

or Cancel Already have a watchlist? Log In

May 13, 2020 (AmericaNewsHour) -- Research Nester released a report titled “Cancer Vaccines Market: Global Demand Analysis & Opportunity Outlook 2028” which delivers detailed overview of the  global cancer vaccines market  in terms of market segmentation by vaccine, by indication, by technology and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

The World Health Organization reported that cancer is the second leading cause of death globally, with around 9.6 million deaths in 2018. Around 1 in 6 deaths are as a result of cancer and about 70% of deaths from cancer take place in middle and low income countries. Moreover, it states that infections which cause cancer, such as hepatitis virus and human papilloma virus (HPV), are responsible for around 25% of cancer cases in low and middle income regions.

The market for cancer vaccines is projected to attain a CAGR of around 17.5% over the forecast period, i.e., 2020-2028. The market is segmented by vaccine, by indication, by technology and by region. Based on technology, the cancer vaccines market is segmented into recombinant vaccine, dendritic cells vaccine, whole cell vaccine, adjuvant vaccine and viral vector & DNA vaccine. According to the National Cancer Institute, the vaccines for prevention of disease causing HPV that are approved for use in the United States prevent infection from HPV type 16 and 18, which are estimated to cause around 70% of all cervical cancers.

Get Exclusive Sample Report Copy Of This Report @  https://www.researchnester.com/sample-request-2402

On the basis of regional analysis, the cancer vaccines market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Cancer vaccines market in North America is anticipated to hold the leading share in the market as a result of highly developed healthcare infrastructure as well as presence of leading key players in the market in the region, especially in the United States. The market in Asia Pacific is projected to grow at the highest rate over the forecast period as a result of rising cases of cancer in the region.

Side Effects Associated with Alternate Cancer Treatments to Drive Market Growth

There are certain side effects associated with existing treatments for cancer such as chemotherapy and radiotherapy including hair loss, weight loss and others. To avoid these, the demand for alternate treatment methods such as cancer vaccines, which are safer and highly effective, is anticipated to increase over the forecast period. However, the high cost of cancer vaccines on account of continuous developments and entrance of improved vaccines in the market on a regular basis is predicted to hamper the market growth.

This report also provides the existing competitive scenario of some of the key players of the global cancer vaccines market which includes company profiling of AstraZeneca (lon:AZN), Bristol-Myers Squibb Company /zigman2/quotes/202559280/composite BMY -0.63% , GlaxoSmithKline plc. (lon:GSK), Sanofi (epa:SAN), Merck & Co Inc /zigman2/quotes/209956077/composite MRK +1.04% , Astellas Pharma Inc. (tyo:4503), VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV +7.43% , Moderna, Inc. /zigman2/quotes/205619834/composite MRNA -2.43% , Advaxis Immunotherapies and Galena Biopharma. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global cancer vaccines market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Get Exclusive Sample Report Copy Of This Report @  https://www.researchnester.com/sample-request-2402

About Research Nester:

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:

AJ Daniel

Email:  sales@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

The post Cancer Vaccines Market- Revenue Growth, Market Status / CAGR of around 17.5% over the forecast period, 2020-2028 appeared first on America News Hour .

COMTEX_365684850/2606/2020-05-13T13:54:45

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com . You can also contact MarketWatch Customer Service via our Customer Center .

/zigman2/quotes/202559280/composite
US : U.S.: NYSE
$ 63.24
-0.40 -0.63%
Volume: 7.75M
Aug. 13, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
2.85%
Market Cap
$143.44 billion
Rev. per Employee
$968,283
loading...
/zigman2/quotes/209956077/composite
US : U.S.: NYSE
$ 83.54
+0.86 +1.04%
Volume: 7.11M
Aug. 13, 2020 4:02p
P/E Ratio
20.34
Dividend Yield
2.92%
Market Cap
$209.12 billion
Rev. per Employee
$615,159
loading...
/zigman2/quotes/201705917/composite
US : U.S.: Nasdaq
$ 3.76
+0.26 +7.43%
Volume: 5.31M
Aug. 13, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$809.19 million
Rev. per Employee
$29,955
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 67.83
-1.69 -2.43%
Volume: 15.06M
Aug. 13, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$27.43 billion
Rev. per Employee
$177,721
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.